Case Report: Take a Second Look: Covid-19 Vaccination-Related Cerebral Venous Thrombosis and Thrombotic Thrombocytopenia Syndrome
Open Access
- 22 November 2021
- journal article
- research article
- Published by Frontiers Media SA in Frontiers in Neurology
- Vol. 12, 763049
- https://doi.org/10.3389/fneur.2021.763049
Abstract
We present two cases of ChAdOx1 nCov-19 (AstraZeneca)-associated thrombotic thrombocytopenia syndrome (TTS) and cerebral venous sinus thrombosis (CVST). At the time of emergency room presentation due to persistent headache, blood serum levels revealed reduced platelet counts. Yet, 1 or 4 days after the onset of the symptom, the first MR-angiography provided no evidence of CVST. Follow-up imaging, performed upon headache refractory to nonsteroidal pain medication verified CVST 2–10 days after initial negative MRI. Both the patients received combined treatment with intravenous immunoglobulins and parenteral anticoagulation leading to an increase of platelet concentration in both the individuals and resolution of the occluded cerebral sinus in one patient.This publication has 17 references indexed in Scilit:
- Frequency of Thrombocytopenia and Platelet Factor 4/Heparin Antibodies in Patients With Cerebral Venous Sinus Thrombosis Prior to the COVID-19 PandemicJAMA, 2021
- Diagnosis and Management of Cerebral Venous Sinus Thrombosis With Vaccine-Induced Immune Thrombotic ThrombocytopeniaStroke, 2021
- Thrombotic Thrombocytopenia after Ad26.COV2.S VaccinationThe New England Journal of Medicine, 2021
- COVID-19 vaccine-associated cerebral venous thrombosis in GermanyPublished by Cold Spring Harbor Laboratory ,2021
- Recanalization after cerebral venous thrombosis. A randomized controlled trial of the safety and efficacy of dabigatran etexilate versus dose-adjusted warfarin in patients with cerebral venous and dural sinus thrombosisInternational Journal of Stroke, 2021
- Clinical Features and Short-term Outcomes of 102 Patients with Coronavirus Disease 2019 in Wuhan, ChinaClinical Infectious Diseases, 2020
- Cerebral Venous Thrombosis: an UpdateCurrent Neurology and Neuroscience Reports, 2019
- Risk factors for recurrent venous thromboembolism in the European collaborative paediatric database on cerebral venous thrombosis: a multicentre cohort studyThe Lancet Neurology, 2007